Catalyst Wire Dossier Catalyst Wire Dossier

Lactobacillus reuteri NCIMB 30242 probiotic capsule

Lactobacillus reuteri NCIMB 30242 · Micropharma Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lactobacillus reuteri NCIMB 30242 probiotic capsule, covering 2014-06-26 to 2014-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of a One-a-Day L. Reuteri NCIMB 30242 Probiotic Supplement Capsule [Phase 2]

See pricing